Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions

Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions

Paediatric otolaryngological disorders represent a substantial proportion of primary care consultations and emergency presentations in childhood. Understanding the unique anatomical and physiological maturation of the paediatric craniomaxillofacial structures—most notably the Eustachian tube and pharyngeal lymphoid ring—is critical for managing otitis media, preventing developmental delays secondary to hearing impairment, and diagnosing life-threatening upper airway obstruction.

---

Anatomy and Physiology of the Paediatric Eustachian Tube

The Eustachian tube (pharyngotympanic tube) connects the middle ear cavity to the nasopharynx. Its fundamental physiological functions are: (1) middle ear pressure ventilation and equilibration, (2) mucociliary clearance of middle ear secretions into the nasopharynx, and (3) acoustic and functional protection against retrograde nasopharyngeal secretions and pathogen entry.

                     [Eustachian Tube Comparison]
  
        Adult Anatomy                           Paediatric Anatomy
   - Length: ~36 mm                        - Length: ~18 mm (half adult length)
   - Angle: 45 degrees downward             - Angle: ~10 degrees (almost horizontal)
   - Rigid elastic cartilage                - Soft, flaccid cartilage (high compliance)
   - Robust tensor veli palatini angle      - Less efficient active tensor dilation
   - Protective against reflux              - Facile retrograde reflux of secretions

Anatomical Predispositions in Early Childhood

• Length and Orientation: In infants and children under 7 years of age, the Eustachian tube is approximately half the adult length (18 mm vs 36 mm) and lies in an almost horizontal plane at an angle of approximately $10^\circ$, compared to the steep $45^\circ$ downward incline in adults. This horizontal orientation significantly degrades gravitational drainage.
• Cartilage Compliance: Paediatric tubal cartilage is softer, thinner, and structurally flaccid. It lacks the tensile rigidity required to prevent dynamic collapse under negative middle ear pressure.
• Muscular Function: The active opening of the Eustachian tube during swallowing, yawning, or crying is mediated primarily by the tensor veli palatini muscle. In infants, the muscle fibers insert at an unfavorable mechanical angle into the tubal cartilage, resulting in inefficient active dilation.
• Adenoidal Interaction: The pharyngeal tonsils (adenoids) are situated in close proximity to the pharyngeal ostium of the Eustachian tube (torus tubarius). Adenoid hypertrophy causes mechanical tubal obstruction, while chronic adenoiditis serves as a persistent bacterial biofilm reservoir (S. pneumoniae, H. influenzae, M. catarrhalis), seeding the middle ear.
• Craniofacial and Environmental Risk Factors: Children with cleft palate (abnormal tensor veli palatini insertion into the hard palate), Down syndrome (hypotonia and midfacial hypoplasia), supine bottle feeding, exposure to passive household tobacco smoke, and group daycare attendance have exceptionally high incidences of tubal dysfunction and middle ear disease.

---

Acute Otitis Media (AOM)

Acute Otitis Media is an acute suppurative infectious process of the middle ear cleft, peaking in incidence between 6 and 18 months of age.

Microbial Etiology

• Viral Priming: Upper respiratory tract viral infections (RSV, rhinovirus, influenza, parainfluenza, adenovirus, human metapneumovirus) precede bacterial AOM in over 80% of episodes. Viral replication induces nasopharyngeal inflammation, mucosal ciliary dyskinesia, and Eustachian tube obstruction, generating negative middle ear pressure that aspirates nasopharyngeal secretions.
• Bacterial Pathogens:
  1. Streptococcus pneumoniae: Gram-positive diplococci; accounts for 30% to 40% of cases. Although pneumococcal conjugate vaccines (PCV13, PCV15, PCV20) have reduced vaccine-serotype disease, non-vaccine serotypes frequently cause acute suppuration, high fevers, and suppurative complications.
  2. Haemophilus influenzae: Non-typeable H. influenzae (NTHi) represents 40% to 50% of contemporary bacterial isolates. Approximately 30% to 40% of NTHi strains produce beta-lactamases. NTHi is characteristically associated with bilateral AOM and concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome).
  3. Moraxella catarrhalis: Gram-negative diplococci; accounts for 10% to 15% of cases. Over 90% produce beta-lactamases, though it is more prone to spontaneous clinical resolution.
  4. Streptococcus pyogenes (Group A Streptococcus): Seen in older children; causes aggressive tympanic membrane necrosis and high mastoiditis rates.

Diagnostic Criteria

Under international and European consensus guidelines, a definitive diagnosis of AOM requires three concurrent elements:

1. Acute Onset: Rapid appearance of signs and symptoms of middle ear inflammation (ear pain, pulling/tugging at the ear, irritability, disturbed sleep, high fever).
2. Middle Ear Effusion (MEE): Demonstrated via pneumatic otoscopy (absent or markedly reduced tympanic membrane motility) or tympanometry.
3. Distinct Tympanic Membrane Inflammation: Characterized by distinct, moderate-to-severe bulging of the tympanic membrane (the single most specific physical sign!), intense erythema, or acute spontaneous purulent otorrhoea.

                  [AOM Management: AAP Framework, Age >=6 Months]
                                      |
        +-----------------------------+-----------------------------+
        |                                                           |
[IMMEDIATE ANTIBIOTICS]                              [OBSERVATION MAY BE CHOSEN]
  - Otorrhoea or severe illness                        - Non-severe unilateral AOM at 6–23 mo
  - Fever >=39 C or moderate/severe otalgia             - Non-severe unilateral OR bilateral
    or otalgia lasting >=48 h                            AOM at >=24 mo
  - Bilateral AOM at 6–23 mo                           - Reliable follow-up; start antibiotics
  - High-risk children need individual assessment       if worsening or not improving in 48–72 h
          Analgesia for all. Infants <6 mo need prompt clinical assessment.

Antibiotic Stratification and Dosing

The doses below follow the AAP framework. NICE NG91 instead permits no, back-up or immediate antibiotics for selected children under 2 with bilateral AOM or those with otorrhoea; immediate antibiotics are indicated if systemically very unwell or at high risk of complications.

• First-Line Antimicrobial: High-dose oral Amoxicillin at 80 to 90 mg/kg/day divided into two doses (maximum 2 to 3 g/day). High-dose amoxicillin achieves middle ear fluid concentrations exceeding the minimum inhibitory concentration (MIC) required to overcome penicillin-binding protein (PBP) mutations in intermediate- and highly resistant strains of Streptococcus pneumoniae.
• Second-Line / Beta-Lactamase Coverage: Amoxicillin-clavulanic acid (Co-amoxiclav) at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate (a 14:1 ratio formulation designed to minimize clavulanate-induced diarrhea). Indicated when:
  1. The child fails to improve after 48 to 72 hours of high-dose amoxicillin.
  2. The child received amoxicillin within the preceding 30 days.
  3. The child presents with concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome, highly predictive of beta-lactamase-producing NTHi).
• Duration of Therapy: 10 days for children $<2$ years or severe disease; for mild-to-moderate illness, 7 days at ages 2–5 and 5–7 days at ages >=6 years.
• Suppurative Complications:
  • Acute Mastoiditis: Spread of middle ear infection into the mastoid air cells, causing osteitis and periosteal breakdown. Clinically characterized by postauricular erythema, fluctuant swelling, tenderness, obliteration of the retroauricular crease, and anterior-inferior protrusion (proptosis) of the auricle. Mandates immediate hospital admission, IV broad-spectrum antibiotics (IV ceftriaxone), and emergency ENT evaluation.
  • Other Complications: Subperiosteal abscess (Bezold's abscess in the sternocleidomastoid, Luc's abscess), facial nerve palsy (CN VII neuropraxia), acute suppurative labyrinthitis, and intracranial spread (meningitis, epidural/brain abscess, sigmoid lateral sinus thrombosis).

---

Otitis Media with Effusion (OME / 'Glue Ear')

Otitis Media with Effusion denotes the presence of non-purulent fluid collection within the middle ear cleft without accompanying signs or symptoms of acute systemic illness or acute tympanic membrane inflammation.

Natural History and Clinical Consequences

• Epidemiology: OME affects up to 80% to 90% of children before school entry, peaking at ages 2 and 5 years. Over 75% of episodes resolve spontaneously within 3 months.
• Clinical Presentation: Unlike AOM, OME produces no acute fever or otalgia. Instead, it manifests with insidious, fluctuating conductive hearing loss (typically 20 to 40 dB HL). Parents and teachers report frequent requests for repetition, high television volume, behavioral inattention, speech clarity deterioration, and expressive language developmental delay.
• Otoscopic Findings: Tympanic membrane is retracted or in a neutral position, exhibiting a dull, yellowish, amber, or pearly-grey discoloration; prominent lateral process and shortened handle of the malleus; loss of the normal cone of light; and visible air-fluid levels or intratympanic fluid bubbles.

              [Jerger Tympanometric Curves: Schematic]

 Type A: normal           Type B: flat              Type C: negative pressure
 Compliance              Compliance               Compliance
     ^                       ^                        ^
     |    /\                 |                        | /\
     |___/  \___             |__________              |/  \_______
       -200 0 +200             -200 0 +200              -200 0 +200
 Peak near 0 daPa          No distinct peak          Peak below −150 daPa
 Pressure axis in daPa; Type B interpretation also requires ear-canal volume.

Tympanometry Interpretation (Jerger Classification)

• Type A: Normal middle ear aeration and compliance. Peak occurs near atmospheric pressure ($-100$ to $+100$ daPa).
• Type B (Flat Curve):
  • Normal Canal Volume (0.3 to 1.0 mL): Diagnostic of middle ear fluid (OME) or severe membrane thickening. The fluid column resists acoustic admittance.
  • Large Canal Volume ($>1.5$ to 2.0 mL): Diagnostic of a tympanic membrane perforation or a patent tympanostomy tube (grommet), where the instrument measures middle ear plus canal volume.
• Type C: Compliance peak shifted significantly into negative pressure ($<-150$ to $-200$ daPa). Reflects Eustachian tube dysfunction; it does not alone confirm or exclude middle ear fluid, so correlate with otoscopy.

Grommet (Tympanostomy Tube) Indications

Antihistamines, decongestants, systemic/intranasal corticosteroids and antibiotics are not recommended for OME.

For bilateral OME persisting >=3 months with hearing loss, discuss the effects on communication, learning and daily life. Consider grommets through shared decision-making; hearing aids, listening support and, if the child can engage, autoinflation are alternatives. Earlier intervention may be needed when hearing difficulty substantially affects daily life.

In children at developmental risk (e.g., Down syndrome, cleft palate, existing SNHL or developmental/language difficulties), AAO guidance permits tubes when OME is likely to persist, indicated by a flat Type B tympanogram or documented effusion for >=3 months; risk status alone is not an automatic indication.

Recurrent AOM may justify tubes at >=3 episodes in 6 months or >=4 in 12 months (at least one in the preceding 6 months); offer tubes only if middle ear effusion is present at the candidacy assessment.

• Structural Changes: Deep tympanic retraction pockets or ossicular erosion warrant specialist assessment to prevent cholesteatoma and lasting damage.
• Adenoidectomy: AAO guidance permits adjunctive adenoidectomy at >=4 years, or earlier for nasal obstruction/chronic adenoid disease. NICE advises considering it with grommets unless there is a palatal abnormality. Discuss the applicable national policy and risks.
• Benefits and Risks: Tubes can improve hearing while functioning, but benefit is not guaranteed or permanent. Discuss otorrhoea, tympanosclerosis and persistent perforation; reassess hearing after surgery.

---

Childhood Hearing Impairment: UNHS and Etiological Evaluation

Permanent childhood hearing loss occurs in 1 to 2 per 1,000 live births. Early audiological habilitation within the first 6 months of life is decisive for normal cortical auditory pathway wiring and spoken language acquisition.

Universal Newborn Hearing Screening (UNHS): The 1-3-6 Benchmark

International guidelines mandate the 1-3-6 target:

• Screening by 1 month of age
• Audiological diagnostic confirmation by 3 months of age
• Initiation of intervention (hearing aids, speech therapy) by 6 months of age

                  [Universal Newborn Hearing Screening]
                                    |
         +--------------------------+--------------------------+
         |                                                     |
[Well-Baby Nursery]                                   [NICU Graduates (>48h)]
  - Transient Evoked Otoacoustic Emissions (TEOAE)      - Automated Auditory Brainstem
  - Measures outer hair cell micromechanics               Response (AABR) MANDATORY
  - Quick, sensitive to cochlear deafness               - Detects neural dyssynchrony and
  - Fails to detect auditory neuropathy                   Auditory Neuropathy Spectrum (ANSD)

1. Transient Evoked Otoacoustic Emissions (TEOAE): A miniature probe in the ear canal delivers acoustic clicks and measures sound waves generated by the electromotile outer hair cells of the organ of Corti. A 'pass' shows detectable outer-hair-cell responses under screening conditions; it does not establish a diagnostic hearing threshold or exclude all hearing loss. However, TEOAE cannot evaluate neural pathways beyond the cochlea; an infant with intact cochlear hair cells but total auditory nerve disruption will erroneously register a normal 'pass'.
2. Automated Auditory Brainstem Response (AABR): Surface scalp electrodes measure electrophysiological neural activity (specifically Wave V) generated from the cochlear nerve and brainstem auditory nuclei in response to acoustic stimuli. AABR is mandatory for all NICU graduates (infants with gestational age $<32$ weeks, severe perinatal asphyxia, ECMO, hyperbilirubinemia requiring exchange transfusion, or ototoxic drug exposure) because these high-risk neonates have a high prevalence of Auditory Neuropathy Spectrum Disorder (ANSD).

Sensorineural Hearing Loss (SNHL): Etiologies

---

Upper Airway Conditions: Recurrent Tonsillitis, OSA, and Epistaxis

Recurrent Acute Tonsillitis: The Paradise Criteria

For recurrent throat infection, the Paradise criteria identify children in whom tonsillectomy may be offered after discussing benefits and risks. Other indications include OSA; modifying factors such as PFAPA, antibiotic intolerance or recurrent peritonsillar abscess may also support surgery.

[The Paradise Criteria for Tonsillectomy]
  - Frequency Thresholds:
    * >=7 episodes in the preceding 12 months; OR
    * >=5 episodes per year for each of the preceding 2 consecutive years; OR
    * >=3 episodes per year for each of the preceding 3 consecutive years
                         +
  - Documented Clinical Features (for each episode):
    * Fever >=38.3 °C (101 °F); OR
    * Cervical lymphadenopathy (tender or >2 cm); OR
    * Tonsillar exudate; OR
    * Positive swab / RADT for Group A Streptococcus
                         +
  - Adequate Medical Therapy:
    * Appropriate antimicrobials for proven or suspected streptococcal episodes

Paediatric Obstructive Sleep Apnoea (OSA)

• Pathophysiology: Sleep-induced loss of upper airway neuromuscular tone superimposed upon anatomical upper airway narrowing. In children aged 2 to 8 years, the predominant anatomical driver is adenotonsillar hypertrophy.
• Clinical Signs: Habitual loud snoring, witnessed nocturnal pauses, gasping, choking, paradoxical inward thoracic motion during inspiration, restless sleep in hyperextended neck postures, morning headaches, secondary daytime enuresis, and neurobehavioral daytime morbidity (hyperactivity, impulsivity, poor school attention mimicking ADHD). Severe, longstanding OSA induces chronic alveolar hypoventilation, pulmonary vasoconstriction, pulmonary arterial hypertension, and cor pulmonale.
• Diagnostic Gold Standard: In-laboratory overnight Polysomnography (PSG). Paediatric OSA is defined as an Apnoea-Hypopnoea Index (AHI) >=1 event per hour (mild: AHI 1 to $<5$; moderate: AHI 5 to $<10$; severe: AHI >=10 events/hr).
• Management: Surgical adenotonsillectomy is the definitive first-line therapeutic intervention in otherwise healthy children with adenotonsillar hypertrophy, demonstrating marked resolution of airway obstruction and behavioral improvement in $>80\%$ of patients.

Paediatric Epistaxis

• Vascular Anatomy: Over 90% of childhood epistaxis originates on the anterior-inferior nasal septum at Little's area, corresponding to Kiesselbach's plexus. This is a rich, fragile submucosal arterial anastomosis formed by five vessels: (1) Anterior ethmoidal artery, (2) Posterior ethmoidal artery, (3) Sphenopalatine artery, (4) Greater palatine artery, and (5) Superior labial artery (septal branch).
• First-Aid Protocol: The child must sit completely upright with the head tilted slightly forward (never backward, which directs blood into the hypopharynx, causing gastric irritation, vomiting, and aspiration risk). Firm, continuous digital pressure must be applied to the soft, compressible anterior lower third of the nose (nasal alae) for a continuous 10 to 15 minutes without releasing pressure to inspect.
• Medical Therapy & Cautery:
  • Topical Antiseptics: Naseptin cream (chlorhexidine and neomycin; current formulation is arachis-oil-free—check allergy to its ingredients) or mupirocin applied twice daily for 2 to 4 weeks eradicates S. aureus vestibulitis and allows re-epithelialization.
  • Chemical Cautery: Silver nitrate (75%) applicators applied under topical local anesthesia to prominent, bleeding septal vessels.

• Red Flags for Neoplasm or Bleeding Diathesis:
  • Coagulopathies: Spontaneous, recurrent, bilateral epistaxis, gingival bleeding, petechiae, or hemarthroses warrants screening for von Willebrand disease, immune thrombocytopenia (ITP), or hemophilia.
  • Juvenile Nasopharyngeal Angiofibroma (JNA): A benign but locally aggressive, non-capsulated, richly vascular tumor arising in the sphenopalatine foramen, occurring almost exclusively in adolescent males (aged 10 to 18 years). Presents with recurrent, unprovoked, massive unilateral epistaxis and progressive unilateral nasal obstruction. Biopsy in an outpatient setting is ABSOLUTELY CONTRAINDICATED due to catastrophic, life-threatening hemorrhage. Diagnosis mandates contrast CT/MRI and diagnostic angiography.